1. From the Division of Hematology/Oncology, Department of Medicine, University of California, San Diego; Department of Cell Signaling Research, BD PharMingen; Department of Medicine, Howard Hughes Medical Institute, University of California, San Francisco; and the Chronic Lymphocytic Leukemia (CLL) Research Consortium, University of California, San Diego.